These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5134260)

  • 41. [Serum insulin and growth hormone during glucose loading in liver cirrhosis].
    Schatz H; Paumgartner G; Brunner H; Höfer R; Grabner G
    Wien Z Inn Med; 1971; 52(1):41-6. PubMed ID: 5540818
    [No Abstract]   [Full Text] [Related]  

  • 42. [Coefficient of glucose assimilation and blood sugar curves following administration of tolbutamide to patients with chronic hepatitis].
    Ciba T; Sowa J
    Pol Arch Med Wewn; 1974 Nov; 52(5):457-64. PubMed ID: 4427794
    [No Abstract]   [Full Text] [Related]  

  • 43. Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans.
    Lewis GF; Vranic M; Giacca A
    Am J Physiol; 1998 Jul; 275(1):E177-86. PubMed ID: 9688888
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum growth hormone, serum immunoreactive insulin and blood glucose response to intravenous tolbutamide in postmenopausal women with and without natural oestrogen therapy.
    Syvälahti E; Erkkola R; Punnonen R; Rauramo L
    Acta Pharmacol Toxicol (Copenh); 1976 Mar; 38(3):177-85. PubMed ID: 988954
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of tolbutamide and hepatic extraction of insulin and glucagon and hepatic glucose output in anesthetized dogs.
    Ishida T; Chou MC; Lewis RM; Hartley CJ; Entman M; Field JB
    Endocrinology; 1981 Aug; 109(2):443-50. PubMed ID: 7018888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin sensitivity, insulin secretion and glucose effectiveness in diabetic and non-diabetic cirrhotic patients.
    Kruszynska YT; Harry DS; Bergman RN; McIntyre N
    Diabetologia; 1993 Feb; 36(2):121-8. PubMed ID: 8458526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Insulin response to glucose or glucagon in subclinical diabetes previously injected with tolbutamide.
    Ohneda A; Watanabe K; Maruhama Y; Itabashi H; Horigome K
    Tohoku J Exp Med; 1977 Jan; 121(1):27-32. PubMed ID: 835136
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of enteric hormones on insulin secretion.
    Kahil ME; McIlhaney GR; Jordan PH
    Metabolism; 1970 Jan; 19(1):50-7. PubMed ID: 5410662
    [No Abstract]   [Full Text] [Related]  

  • 49. Interrelationship of glucagon, insulin and glucose. The insulinogenic effect of glucagon.
    Samols E; Marri G; Marks V
    Diabetes; 1966 Dec; 15(12):855-66. PubMed ID: 5957476
    [No Abstract]   [Full Text] [Related]  

  • 50. [Glucagon mediated insulin release in man].
    Marks V; Salmols E
    Acta Diabetol Lat; 1968 Oct; 5 Suppl 1():285-308. PubMed ID: 4907221
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies in prediabetes. Insulin response to oral glucose, intravenous tolbutamide and rapid intravenous glucose infusion in genetic prediabetics.
    Serrano-Rios M; Ramos F; Rodriguez-Miñon JL; Vivanco F
    Diabetologia; 1970 Aug; 6(4):392-8. PubMed ID: 5456764
    [No Abstract]   [Full Text] [Related]  

  • 52. Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen.
    Vinik AI; Jackson WP; Keller P; Marine N
    Diabetologia; 1968 Aug; 4(4):203-9. PubMed ID: 5738360
    [No Abstract]   [Full Text] [Related]  

  • 53. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
    McMahon MM; O'Brien PC; Service FJ
    Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new method for comparing portal and peripheral venous insulin delivery in humans: tolbutamide versus insulin infusion.
    Lewis GF; Steiner G; Polonsky KS; Weller B; Zinman B
    J Clin Endocrinol Metab; 1994 Jul; 79(1):66-70. PubMed ID: 8027255
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
    Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hepatic cirrhosis (non hemochromatosic) Diabetes mellitus. III. Secretion of insulin in cirrhotic patients tolerant and non tolerant to oral glucose overload].
    Cerdán Vallejo A; Jolin Buzo T; Sánchez Franco F; Ortíz Vázquez J
    Rev Clin Esp; 1974 Sep; 134(5):441-8. PubMed ID: 4438739
    [No Abstract]   [Full Text] [Related]  

  • 57. [Carbohydrate metabolism in liver cirrhosis. II. Insulinemia following loading with glucose alone and in combination with glucagon and tolbutamide].
    Smoczyński M
    Pol Arch Med Wewn; 1975 Nov; 54(5):445-53. PubMed ID: 1197058
    [No Abstract]   [Full Text] [Related]  

  • 58. [Evaluation of liver function by means of the glucagon test].
    Brunner H; Grabner G; Michalek P; Paumgartner G
    Wien Z Inn Med; 1968; 49(11):409-17. PubMed ID: 5737590
    [No Abstract]   [Full Text] [Related]  

  • 59. [Immunologically measurable insulin(IMI) in normal, obese and obese, diabetic subjects after intravenous administration of glucose, tolbutamide and glucagon].
    Melani F; Lawecki J; Bartelt KM; Pfeiffer EF
    Diabetologia; 1967 Oct; 3(5):422-6. PubMed ID: 5620801
    [No Abstract]   [Full Text] [Related]  

  • 60. Activation of adenyl cyclase in a pancreatic islet cell adenoma by glucagon and tolbutamide.
    Levey GS; Schmidt WM; Mintz DH
    Metabolism; 1972 Feb; 21(2):93-8. PubMed ID: 4333162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.